KNSA | Kiniksa Pharmaceuticals, Ltd.
Quick infos Trade prices Volume: Market Cap: 749.64M Prev closed: 22.46 Open: 22.6 High: 23 Low: 21.65 52 week low: 10.3 52 week high: 28.67 Dividends: No Dividends Next ER: November 4, 2021
Company Profile Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines designed to modulate immunological signaling pathways for patients suffering from debilitating diseases with significant unmet medical need.
Earnings History Date EPS / Forecast Revenue / Forecast March 10, 2022 November 1, 2021 -0.44 / -0.646812.1M / 10.23MBeat! August 3, 2021 -0.61 / -0.84677.7M / 4.29MBeat! May 5, 2021 - / -0.6833- / -February 23, 2021 -0.79 / -0.636- / -view more
Historical Data Date Price Open High Low Vol Change ER Nov 12, 2021 13.39 13.03 13.45
13.03
151.22K 1.13% Nov 11, 2021 13.24 13.75 13.77
13.06
223.21K -3.5% Nov 10, 2021 13.72 14.10 14.39
13.69
191.99K -4.12% Nov 9, 2021 14.31 14.67 14.91
14.22
282.13K -1.92% Nov 8, 2021 14.59 14.80 15.14
14.50
296.29K -0.95% Nov 5, 2021 14.73 14.83 15.13
14.50
342.01K -0.94% Nov 4, 2021 14.87 14.38 15.15
14.00
498.25K -1.26% Nov 3, 2021 15.06 14.63 15.10
14.38
664.94K -0.59% Nov 2, 2021 15.15 12.90 15.24
12.78
1.70M 19.01% Nov 1, 2021 12.73 10.99 13.55
10.59
1.20M 22.52% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2015 Employees:135 News
Kiniksa posts a record gain as outlook beats estimates seekingalpha.com Nov 2, 2021 3:22 am Kiniksa Pharmaceuticals EPS beats by $0.19, beats on revenue seekingalpha.com Nov 1, 2021 8:05 pm Kiniksa Pharmaceuticals Q3 2021 Earnings Preview seekingalpha.com Nov 1, 2021 12:56 am
Kiniksa Launches Patient Registry (RESONANCE) for Recurrent Pericarditis finance.yahoo.com Mar 2, 2021 8:00 am Can Kiniksa Pharmaceuticals Ltd (KNSA) Stock Rise to the Top of Healthcare Sector Tuesday? investorsobserver.com Feb 25, 2021 9:22 am
Kiniksa Reports Fourth Quarter and Full-Year 2020 Financial Results and Corporate and Pipeline Activity finance.yahoo.com Feb 23, 2021 8:00 am Flying taxi maker EHang shares rebound 40% after response to short-seller reportdoor.com Feb 18, 2021 9:22 am Warren Buffett's favorite indicator is at a dangerous level, but he just bought these stocks anyway reportdoor.com Feb 18, 2021 9:22 am Where Does Kiniksa Pharmaceuticals Ltd (KNSA) Stock Fall in the Biotechnology Field? investorsobserver.com Feb 18, 2021 9:22 am Brent Oil Passes $65 With US Crisis Now a Global Supply Shock reportdoor.com Feb 18, 2021 9:22 am 3 Top Biotech Stocks With Major Catalysts Approaching nasdaq.com Feb 18, 2021 9:22 am Kiniksa Pharmaceuticals (KNSA) Chairman & CEO Sanj K Patel Sold $1.3 million of Shares finance.yahoo.com Feb 11, 2021 9:22 am Kiniksa reports positive data for COVID-19 respiratory syndrome candidate seekingalpha.com Aug 4, 2021 4:01 am Arcturus Therapeutics, Translate Bio leads healthcare gainers; Neuronetics, Bright Health among major losers seekingalpha.com Aug 3, 2021 11:03 pm Kiniksa Pharmaceuticals EPS misses by $0.66, beats on revenue seekingalpha.com Aug 3, 2021 8:22 pm RFIL, KC, IMUX and GBS among after-hours movers seekingalpha.com Jul 15, 2021 5:40 am ETTX, SNCY, IMRA and LMAT among after-hours movers seekingalpha.com Jul 14, 2021 5:40 am CRISPR, Omeros among “actionable” SMID-cap biopharma for H2 2021 at BofA seekingalpha.com Jul 3, 2021 2:10 am Kiniksa issued U.S. patent for treatment of recurrent pericarditis seekingalpha.com Jun 9, 2021 4:05 am Kiniksa outlines development path for mavrilimumab after FDA feedback seekingalpha.com Jun 8, 2021 8:06 pm This company doesn't provide a dividend.
Key Persons Talk about Kiniksa Pharmaceuticals, Ltd. below in comments section below. Do you think you'll buy? Do you already have active trades now?
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
